ArticleLife (Basel, Switzerland)2022

Super-Responders in Moderate-Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives.

Ricardo Ruiz-Villaverde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.